Discovery: Leverage Intelligence
Quickly solving a problem. Using real-life health related data to inform strategy. Shift from planning assumptions to real-life intelligence – powered by behavior, sentiment and engagement data.
Strategic Insights with Drug-GPT : Leveraging GLP-1 Conversational Data
Sign Up to Stay Ahead of Message Impact
Discover how Pharma marketeers are finally measuring which messages change HCP behavior. Our newsletter shares evidence-led insights powered by DrugVoice and the Message Resonance Score™ so you can predict and prove message impact—before prescriptions are written.
Inside This Session
Join Scott Crae from Talking Medicines, Justin Wyman from Socialgist and Data Intelligence expert Roma English Owen in a fireside chat tackle one of today’s pressing questions: How can real-world conversational data shape more effective pharma marketing? By tapping into real-world audience insights on GLP-1 inhibitors and utilizing both open and closed community data from Socialgist, they demonstrated how AI can drive efficiency and effectiveness while boosting ROI through Curated Conversational Intelligence.
More from The Talking Room
Large Language Models and Regulatory-Grade GLP-1 Content: Challenges and the Need for Accurate Message Measurement
Can large language models truly support regulatory-grade pharmaceutical communication? Learn more in our recent TMLabs briefing session.
Introducing DrugVoice
DrugVoice turns unstructured HCP data into Predictive HCP Intelligence, revealing how scientific messaging lands and influences HCP behavior.